Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain
Open accessThe DOI matches its Crossref record; 98 of the 103 references it cites were found in a registry or an index; 16 of the 40 sources its claims cite were checked for support.
Abstract
There is solid evidence of an association between several psychological flexibility processes, particularly pain acceptance, and adaptation to chronic pain. However, there are relatively few studies on the relationship between pain acceptance and opioid misuse in chronic pain patients. Thus, the aim of the present study was to test a hypothetical model in which pain acceptance would regulate pain sensations and pain-related thoughts and emotions, which would be related to opioid misuse. The sample comprised 140 chronic pain patients attending two hospitals. All patients were receiving pharmacological treatment, including opioid analgesics. Structural equation modelling analyses showed a significant association between higher pain acceptance and lower pain intensity and catastrophizing, and lower levels of anxiety and depression. Only higher anxiety and depression were significantly associated with increased opioid misuse. The results suggest that levels of anxiety, depression, and pain acceptance must be assessed before opioids are prescribed. Pain acceptance implies a relationship with internal events that protects against anxiety and depression and thus against opioid misuse. Acceptance and Commitment Therapy appears to be particularly appropriate for these patients. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Overview
CoChat Summary
## TL;DR
In 140 patients with chronic noncancer pain receiving opioid analgesics, higher pain acceptance was associated with lower pain intensity, catastrophizing, anxiety, and depression. In the final structural equation model, only anxiety and depression were significantly associated with greater opioid misuse, suggesting pain acceptance may protect against misuse indirectly.
## Key findings
- The final sample included 140 chronic pain patients; 115 women and 25 men; mean age 59.24 years (SD = 9.77); average pain duration 17 years (SD = 13.4).
- Pain acceptance showed a high negative association with depression, a medium negative correlation with anxiety, catastrophizing, and pain intensity, and a low negative correlation with opioid misuse.
- In contrast, opioid misuse showed a high positive significant correlation with depression and anxiety and a medium positive significant correlation with pain catastrophizing; the correlation with pain intensity did not reach significance.
- In the final SEM, all path coefficients were statistically significant (p < 0.05), and model fit was good: χ2(df) = 5.18 (6), p = 0.52; RMSEA = 0.00; NNFI = 1.00; CFI = 0.99. Pain acceptance had significant negative paths to pain intensity, catastrophizing, depression, and anxiety, but only depression and anxiety had significant paths to opioid misuse.
## Methods
- Cross-sectional study of patients with chronic noncancer pain recruited from two hospitals between October 2019 and February 2020; eligibility required pain for at least 6 months, age 18–65, no malignancy/terminal illness/psychiatric disorder, and ability to understand Spanish and questionnaires.
- Participants completed a semi-structured interview plus questionnaires assessing pain intensity, pain acceptance (CPAQ-SV, 20 items), pain catastrophizing (2-item CSQ), anxiety and depression (HADS), and current opioid misuse (COMM, 17 items; score ≥9 indicates positive misuse).
- Analyses included descriptive statistics, correlations, reliability via Cronbach’s alpha, and structural equation modelling (SEM) in LISREL 8.80 using Maximum Likelihood estimation and fit indices including Satorra–Bentler chi-square, RMSEA, CFI, and NNFI.
## Limitations
- The paper states that the study relied exclusively on self-report measures, which could have affected results due to shared methodological variance.
- The cross-sectional design means the study precludes causal inferences.
- Generalizability may be limited because women were overrepresented, all participants had long-lasting musculoskeletal pain, the sample had low education level, and most were no longer active workers; the paper also notes that future studies could examine the differential effect of different opioid medications.
- Evident from the text: the study was conducted in a single sample from two hospitals in Spain and excluded people with psychiatric disorder, malignancy, or terminal illness, which may further limit broader applicability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 0 Not valid · 8 Not checked · 22 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous studies have consistently found that patients with high levels of anxiety and depression receiving opioid treatment for chronic pain are at increased risk of developing opioid misuse [80,81,82,83,84,85,86,87,88,89,90].”
§ Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain > 4. Discussion Chronic pain is one of the most significant risk factors for opioid misuse [64]. The majority of people who misuse opioids were initially prescribed these drugs for chronic pain and, over time, departed from the initial medical directions [65,66]. Thus, it is relevant to investigate the role of the psychological factors involved in adjustment to chronic pain and in opioid misuse. There is ample evidence of an association between psychological flexibility processes, particularly pain acceptance, and better adjustment to pain [12,28,29] and preliminary evidence of an association between pain acceptance and a lower risk of opioid misuse in chronic pain patients [39,40,41]. Thus, the present study tested a hypothetical model in which pain acceptance would regulate the experience of pain, including pain intensity, catastrophic pain-related thoughts and emotions, and anxiety and depression. All of these factors are associated with opioid misuse. The results partially supported the postulated model. In particular, a significant association was found between higher pain acceptance and lower pain intensity, lower pain catastrophizing, and lower levels of anxiety and depression. Only higher levels of anxiety and depression were significantly associated with increased opioid misuse. These results are in line with a well-documented finding in the literature: Pain acceptance, defined as the response to pain-related experiences without attempts at control or avoidance and engaging in normal life activities even if pain is present [42], effectively regulates the experience of pain [12,28,29] and, indirectly, opioid misuse through anxiety and depression. Interestingly, we found no association between self-reported pain intensity and opioid misuse. This finding is compatible with those of previous cross-sectional and longitudinal studies [67,68,69,70], which found that self-reported pain intensity contributed minimally to opioid craving. This variable is associated with prescription opioid misuse in chronic pain patients receiving long-term opioid therapy [67,71]. A recent longitudinal study found that the association between pain intensity and opioid misuse disappeared when controlling for negative affect and pain catastrophizing [72]. Instead, and in line with our results, a significant association has been found between the severity of prescription opioid misuse and self-reported anxiety and depression [67]. These results challenge the intuitive assumption that patients crave opioid medication due to pain and the relief that they expect to obtain, and instead suggest that opioid misuse is aimed at mitigating unpleasant emotional states. Several studies have found an association between general measures of prescription opioid misuse and pain catastrophizing, defined as ruminating thoughts about the serious threat that pain represents and the lack of personal resources for coping with it [73,74,75,76,77]. Furthermore, an association has been found between increased pain catastrophizing and an increased likelihood of running out of opioid medication early, even after controlling for the patients’ levels of pain intensity and negative affect [72]. Pain catastrophizing has also been associated with increased cravings for prescription opioids [78]. This study found no evidence of an association between pain catastrophizing and opioid misuse. This finding is similar to that of a previous study [79]. The authors explained the discrepancy between the results and those of previous research in terms of the composition of their sample, which they judged to be more heterogeneous and representative of the population of patients treated at a tertiary pain clinic than samples investigated in previous studies. The discrepancy between our results and those reported in previous studies could be due to the assessment tool we used to measure pain catastrophizing. Previous studies have used the Pain Catastrophizing Scale [80], whereas we used the 2-item CSQ [50]. Although these items proved to be valid and reliable, as their authors recognize, they do not completely capture the entire content domain of the catastrophizing construct, which comprises the aforementioned dimensions of rumination, magnification, and helplessness [80]. The results of the present study suggest that anxiety and depression are associated with the misuse of prescription opioids in patients receiving opioid therapy. The relationship between anxiety and depression and substance abuse in general [81] and opioid misuse in particular is a well-documented finding [82,83]; there is also considerable evidence on the comorbidity of chronic pain and mood disorders [84]. Previous studies have consistently found that patients with high levels of anxiety and depression receiving opioid treatment for chronic pain are at increased risk of developing opioid misuse [80,81,82,83,84,85,86,87,88,89,90]. In fact, theories of addiction propose that escape from and avoidance of negative affect is the predominant motive for addictive drug use [91,92]. This perspective suggests that the mechanism sustaining opioid addiction could be a learned association between opioids and relief from an existing dysphoric state, which is formed and maintained by negative reinforcement [93,94]. In order to understand the mechanisms underlying the association between opioid-related and anxiety-related disorders, recent research has addressed transdiagnostic vulnerability factors [95], and specifically, anxiety sensitivity [96], emotion dysregulation [97], pain-anxiety [89], distress intolerance [98], and acceptance [39,40,41] as in the present study. All these factors refer to maladaptive responses to emotional states that are mainly characterized by avoidance, although there is some degree of overlap between them. Thus, there is a need for these results to be integrated into an overarching theoretical model. In this regard, the Psychological Flexibility Model [14] is promising. Until now, most related studies have focused on acceptance and experiential avoidance. Future research could address the role of all the elements of the model in relation to co-morbid anxiety and depression and opioid misuse in chronic pain patients. A research study [99] found that some of the factors associated with opioid misuse are similar to those associated with opioid prescription. In a sample of patients with noncancer chronic pain, the participants who were prescribed opioids were older, reported higher levels of pain intensity and depressive symptoms and reported lower levels of pain-acceptance than those who had not been prescribed opioids. It could be the case that physicians prescribe opioids more frequently to those patients who are at greater risk of opioid misuse. A future line of research would be to simultaneously study the factors involved in the prescription of opioids and the factors involved in their misuse in the same group of participants.
What the sources say
- Not checked — no full text of the sourcecites [80] Sullivan, 1995, The Pain Catastrophizing Scale: Development and validation, Psychol. Assess. source
- Not checked — no full text of the sourcecites [81] Lai, 2015, Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis, Drug Alcohol Depend. source
- Partly supportedcites [82] Martins, 2012, Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions, Psychol. Med. sourceExperimental — accuracy not yet measured
The Results (self-medication pathway, Table 3; page unavailable) associate baseline mood disorders and generalized anxiety disorder with later nonmedical prescription opioid use. But this was a general-population study of diagnosed disorders, not a study of anxiety and depression levels among patients receiving opioids for chronic pain. The Discussion also says the authors lacked information about where users’ first significant opioid exposure occurred. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [83] Goldner, 2014, Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses, Addict. Behav. source
- Could not verifycites [84] de Heer, E.W., Gerrits, M.M.J.G., Beekman, A.T.F., Dekker, J., van Marwijk, H.W.J., de Waal, M.W.M., Spinhoven, P., Penninx, B.W.J.H., and van der Feltz-Cornelis, C.M. (2014). The association of depression and anxiety with pain: A study from NESDA. PLoS ONE, 9. sourceExperimental — accuracy not yet measured
The Introduction and Results discuss the association of depression and anxiety with chronic pain and pain-related disability. Searches for opioid misuse and opioid treatment found no passage addressing whether patients with anxiety or depression who receive opioids are at increased risk of misuse. (LLM, conf=0.76)
- Partly supportedcites [85] Grattan, 2012, Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse, Ann. Fam. Med. sourceExperimental — accuracy not yet measured
The Abstract reports that, among chronic opioid therapy recipients with no substance-abuse history, depressive symptoms were associated with increased rates of some forms of self-reported opioid misuse. The Opioid Misuse and Depression section says the causal relationship is difficult to determine. The paper does not establish that anxiety increases misuse risk or that patients subsequently develop misuse; page numbers were not supplied. (LLM, conf=0.88)
- Partly supportedcites [86] Gros, 2013, Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence, Am. J. Addict. sourceExperimental — accuracy not yet measured
The Discussion reports that prior research found depression predictive of prescription opioid abuse in patients with chronic pain and recommends monitoring mood or anxiety disorders in patients prescribed opioids. It does not establish that anxiety predicts later misuse: this study examined people already dependent on prescription opioids, and its Conclusions say the cross-sectional design cannot determine temporal order. Page numbers are not provided in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [87] Feingold, 2017, Misuse of prescription opioids among chronic pain patients suffering from anxiety: A cross-sectional analysis, Gen. Hosp. Psychiatry source
- Not checked — no full text of the sourcecites [88] Feingold, 2018, The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study, J. Affect. Disord. source
- Partly supportedcites [89] Rogers, 2018, Pain-related anxiety and opioid misuse in a racially/ethnically diverse young adult sample with moderate/severe pain, Cog. Behav. Ther. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports that pain-related anxiety was associated with several opioid-misuse indicators in young adults with moderate to severe pain. It does not establish the claim for both anxiety and depression: the study did not assess depression separately, did not restrict its sample to patients receiving opioids for chronic pain, and used cross-sectional data that cannot show who later developed misuse. (LLM, conf=0.88)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This perspective suggests that the mechanism sustaining opioid addiction could be a learned association between opioids and relief from an existing dysphoric state, which is formed and maintained by negative reinforcement [93,94].”
§ Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain > 4. Discussion Chronic pain is one of the most significant risk factors for opioid misuse [64]. The majority of people who misuse opioids were initially prescribed these drugs for chronic pain and, over time, departed from the initial medical directions [65,66]. Thus, it is relevant to investigate the role of the psychological factors involved in adjustment to chronic pain and in opioid misuse. There is ample evidence of an association between psychological flexibility processes, particularly pain acceptance, and better adjustment to pain [12,28,29] and preliminary evidence of an association between pain acceptance and a lower risk of opioid misuse in chronic pain patients [39,40,41]. Thus, the present study tested a hypothetical model in which pain acceptance would regulate the experience of pain, including pain intensity, catastrophic pain-related thoughts and emotions, and anxiety and depression. All of these factors are associated with opioid misuse. The results partially supported the postulated model. In particular, a significant association was found between higher pain acceptance and lower pain intensity, lower pain catastrophizing, and lower levels of anxiety and depression. Only higher levels of anxiety and depression were significantly associated with increased opioid misuse. These results are in line with a well-documented finding in the literature: Pain acceptance, defined as the response to pain-related experiences without attempts at control or avoidance and engaging in normal life activities even if pain is present [42], effectively regulates the experience of pain [12,28,29] and, indirectly, opioid misuse through anxiety and depression. Interestingly, we found no association between self-reported pain intensity and opioid misuse. This finding is compatible with those of previous cross-sectional and longitudinal studies [67,68,69,70], which found that self-reported pain intensity contributed minimally to opioid craving. This variable is associated with prescription opioid misuse in chronic pain patients receiving long-term opioid therapy [67,71]. A recent longitudinal study found that the association between pain intensity and opioid misuse disappeared when controlling for negative affect and pain catastrophizing [72]. Instead, and in line with our results, a significant association has been found between the severity of prescription opioid misuse and self-reported anxiety and depression [67]. These results challenge the intuitive assumption that patients crave opioid medication due to pain and the relief that they expect to obtain, and instead suggest that opioid misuse is aimed at mitigating unpleasant emotional states. Several studies have found an association between general measures of prescription opioid misuse and pain catastrophizing, defined as ruminating thoughts about the serious threat that pain represents and the lack of personal resources for coping with it [73,74,75,76,77]. Furthermore, an association has been found between increased pain catastrophizing and an increased likelihood of running out of opioid medication early, even after controlling for the patients’ levels of pain intensity and negative affect [72]. Pain catastrophizing has also been associated with increased cravings for prescription opioids [78]. This study found no evidence of an association between pain catastrophizing and opioid misuse. This finding is similar to that of a previous study [79]. The authors explained the discrepancy between the results and those of previous research in terms of the composition of their sample, which they judged to be more heterogeneous and representative of the population of patients treated at a tertiary pain clinic than samples investigated in previous studies. The discrepancy between our results and those reported in previous studies could be due to the assessment tool we used to measure pain catastrophizing. Previous studies have used the Pain Catastrophizing Scale [80], whereas we used the 2-item CSQ [50]. Although these items proved to be valid and reliable, as their authors recognize, they do not completely capture the entire content domain of the catastrophizing construct, which comprises the aforementioned dimensions of rumination, magnification, and helplessness [80]. The results of the present study suggest that anxiety and depression are associated with the misuse of prescription opioids in patients receiving opioid therapy. The relationship between anxiety and depression and substance abuse in general [81] and opioid misuse in particular is a well-documented finding [82,83]; there is also considerable evidence on the comorbidity of chronic pain and mood disorders [84]. Previous studies have consistently found that patients with high levels of anxiety and depression receiving opioid treatment for chronic pain are at increased risk of developing opioid misuse [80,81,82,83,84,85,86,87,88,89,90]. In fact, theories of addiction propose that escape from and avoidance of negative affect is the predominant motive for addictive drug use [91,92]. This perspective suggests that the mechanism sustaining opioid addiction could be a learned association between opioids and relief from an existing dysphoric state, which is formed and maintained by negative reinforcement [93,94]. In order to understand the mechanisms underlying the association between opioid-related and anxiety-related disorders, recent research has addressed transdiagnostic vulnerability factors [95], and specifically, anxiety sensitivity [96], emotion dysregulation [97], pain-anxiety [89], distress intolerance [98], and acceptance [39,40,41] as in the present study. All these factors refer to maladaptive responses to emotional states that are mainly characterized by avoidance, although there is some degree of overlap between them. Thus, there is a need for these results to be integrated into an overarching theoretical model. In this regard, the Psychological Flexibility Model [14] is promising. Until now, most related studies have focused on acceptance and experiential avoidance. Future research could address the role of all the elements of the model in relation to co-morbid anxiety and depression and opioid misuse in chronic pain patients. A research study [99] found that some of the factors associated with opioid misuse are similar to those associated with opioid prescription. In a sample of patients with noncancer chronic pain, the participants who were prescribed opioids were older, reported higher levels of pain intensity and depressive symptoms and reported lower levels of pain-acceptance than those who had not been prescribed opioids. It could be the case that physicians prescribe opioids more frequently to those patients who are at greater risk of opioid misuse. A future line of research would be to simultaneously study the factors involved in the prescription of opioids and the factors involved in their misuse in the same group of participants.
What the sources say
- Supportedcites [93] Evans, 2016, Neurobiology of opioid dependence in creating addiction vulnerability, F1000Research source
In “Learned association of relief from aversion” (page not provided), the authors propose that relief of dysphoric withdrawal through opioid use creates a learned association, reinforced by repeated cycles of use and withdrawal. They further propose that this association can drive later craving and relapse when negative affect returns, consistent with the claim’s hedged wording. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [94] Koob, 2020, Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement, Biol. Psychiatry source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Instead, and in line with our results, a significant association has been found between the severity of prescription opioid misuse and self-reported anxiety and depression [67].”
§ Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain > 4. Discussion Chronic pain is one of the most significant risk factors for opioid misuse [64]. The majority of people who misuse opioids were initially prescribed these drugs for chronic pain and, over time, departed from the initial medical directions [65,66]. Thus, it is relevant to investigate the role of the psychological factors involved in adjustment to chronic pain and in opioid misuse. There is ample evidence of an association between psychological flexibility processes, particularly pain acceptance, and better adjustment to pain [12,28,29] and preliminary evidence of an association between pain acceptance and a lower risk of opioid misuse in chronic pain patients [39,40,41]. Thus, the present study tested a hypothetical model in which pain acceptance would regulate the experience of pain, including pain intensity, catastrophic pain-related thoughts and emotions, and anxiety and depression. All of these factors are associated with opioid misuse. The results partially supported the postulated model. In particular, a significant association was found between higher pain acceptance and lower pain intensity, lower pain catastrophizing, and lower levels of anxiety and depression. Only higher levels of anxiety and depression were significantly associated with increased opioid misuse. These results are in line with a well-documented finding in the literature: Pain acceptance, defined as the response to pain-related experiences without attempts at control or avoidance and engaging in normal life activities even if pain is present [42], effectively regulates the experience of pain [12,28,29] and, indirectly, opioid misuse through anxiety and depression. Interestingly, we found no association between self-reported pain intensity and opioid misuse. This finding is compatible with those of previous cross-sectional and longitudinal studies [67,68,69,70], which found that self-reported pain intensity contributed minimally to opioid craving. This variable is associated with prescription opioid misuse in chronic pain patients receiving long-term opioid therapy [67,71]. A recent longitudinal study found that the association between pain intensity and opioid misuse disappeared when controlling for negative affect and pain catastrophizing [72]. Instead, and in line with our results, a significant association has been found between the severity of prescription opioid misuse and self-reported anxiety and depression [67]. These results challenge the intuitive assumption that patients crave opioid medication due to pain and the relief that they expect to obtain, and instead suggest that opioid misuse is aimed at mitigating unpleasant emotional states. Several studies have found an association between general measures of prescription opioid misuse and pain catastrophizing, defined as ruminating thoughts about the serious threat that pain represents and the lack of personal resources for coping with it [73,74,75,76,77]. Furthermore, an association has been found between increased pain catastrophizing and an increased likelihood of running out of opioid medication early, even after controlling for the patients’ levels of pain intensity and negative affect [72]. Pain catastrophizing has also been associated with increased cravings for prescription opioids [78]. This study found no evidence of an association between pain catastrophizing and opioid misuse. This finding is similar to that of a previous study [79]. The authors explained the discrepancy between the results and those of previous research in terms of the composition of their sample, which they judged to be more heterogeneous and representative of the population of patients treated at a tertiary pain clinic than samples investigated in previous studies. The discrepancy between our results and those reported in previous studies could be due to the assessment tool we used to measure pain catastrophizing. Previous studies have used the Pain Catastrophizing Scale [80], whereas we used the 2-item CSQ [50]. Although these items proved to be valid and reliable, as their authors recognize, they do not completely capture the entire content domain of the catastrophizing construct, which comprises the aforementioned dimensions of rumination, magnification, and helplessness [80]. The results of the present study suggest that anxiety and depression are associated with the misuse of prescription opioids in patients receiving opioid therapy. The relationship between anxiety and depression and substance abuse in general [81] and opioid misuse in particular is a well-documented finding [82,83]; there is also considerable evidence on the comorbidity of chronic pain and mood disorders [84]. Previous studies have consistently found that patients with high levels of anxiety and depression receiving opioid treatment for chronic pain are at increased risk of developing opioid misuse [80,81,82,83,84,85,86,87,88,89,90]. In fact, theories of addiction propose that escape from and avoidance of negative affect is the predominant motive for addictive drug use [91,92]. This perspective suggests that the mechanism sustaining opioid addiction could be a learned association between opioids and relief from an existing dysphoric state, which is formed and maintained by negative reinforcement [93,94]. In order to understand the mechanisms underlying the association between opioid-related and anxiety-related disorders, recent research has addressed transdiagnostic vulnerability factors [95], and specifically, anxiety sensitivity [96], emotion dysregulation [97], pain-anxiety [89], distress intolerance [98], and acceptance [39,40,41] as in the present study. All these factors refer to maladaptive responses to emotional states that are mainly characterized by avoidance, although there is some degree of overlap between them. Thus, there is a need for these results to be integrated into an overarching theoretical model. In this regard, the Psychological Flexibility Model [14] is promising. Until now, most related studies have focused on acceptance and experiential avoidance. Future research could address the role of all the elements of the model in relation to co-morbid anxiety and depression and opioid misuse in chronic pain patients. A research study [99] found that some of the factors associated with opioid misuse are similar to those associated with opioid prescription. In a sample of patients with noncancer chronic pain, the participants who were prescribed opioids were older, reported higher levels of pain intensity and depressive symptoms and reported lower levels of pain-acceptance than those who had not been prescribed opioids. It could be the case that physicians prescribe opioids more frequently to those patients who are at greater risk of opioid misuse. A future line of research would be to simultaneously study the factors involved in the prescription of opioids and the factors involved in their misuse in the same group of participants.
What the sources say
- Supportedcites [67] Martel, 2014, The association between negative affect and prescription opioid misuse in patients with chronic pain: The mediating role of opioid craving, J. Pain source
The Results (section 3.2, Correlations among measures) report significant correlations between prescription opioid misuse scores and both self-reported anxiety (r = .31, p < .01) and depression (r = .25, p < .05). The Methods (section 2.2) confirm that anxiety and depression were self-reported. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“There is solid evidence of an association between several psychological flexibility processes, particularly pain acceptance, and adaptation to chronic pain.”
- Also stated in: § 1. Introduction · boosted
“There is considerable evidence supporting an association between several psychological flexibility processes—particularly pain acceptance—and adjustment to chronic pain [12].”
§ Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain > Abstract
What the sources say
- Supportedcites [12] McCracken, 2014, The psychological flexibility model: A basis for integration and progress in psychological approaches to chronic pain management, J. Pain source
The Introduction (page not specified) says acceptance is especially prominent among psychological flexibility processes studied in chronic pain and that other processes also have empirical support. The References list studies linking pain acceptance to adjustment and other flexibility processes to functioning in people with chronic pain. The paper cautions that laboratory findings may not fully extend to chronic pain, but the claim is about association, not a causal treatment effect. (LLM, conf=0.86)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Structural equation modelling analyses showed a significant association between higher pain acceptance and lower pain intensity and catastrophizing, and lower levels of anxiety and depression.”
- Also stated in: § 3.3. Structural Equation Modeling · plain
“As expected, pain acceptance had four significant and negative path coefficients to pain intensity, pain catastrophizing, depression, and anxiety.”
- Also stated in: § 4. Discussion Chronic pain is one of the most significant risk factors for opioid misuse [64]. The majority of people who misuse opioids were initially prescribed these drugs for chronic pain and, over time, departed from the initial medical directions [65,66]. Thus, it is relevant to investigate the role of the psychological factors involved in adjustment to chronic pain and in opioid misuse. There is ample evidence of an association between psychological flexibility processes, particularly pain acceptance, and better adjustment to pain [12,28,29] and preliminary evidence of an association between pain acceptance and a lower risk of opioid misuse in chronic pain patients [39,40,41]. Thus, the present study tested a hypothetical model in which pain acceptance would regulate the experience of pain, including pain intensity, catastrophic pain-related thoughts and emotions, and anxiety and depression. All of these factors are associated with opioid misuse. The results partially supported the postulated model. In particular, a significant association was found between higher pain acceptance and lower pain intensity, lower pain catastrophizing, and lower levels of anxiety and depression. Only higher levels of anxiety and depression were significantly associated with increased opioid misuse. These results are in line with a well-documented finding in the literature: Pain acceptance, defined as the response to pain-related experiences without attempts at control or avoidance and engaging in normal life activities even if pain is present [42], effectively regulates the experience of pain [12,28,29] and, indirectly, opioid misuse through anxiety and depression. Interestingly, we found no association between self-reported pain intensity and opioid misuse. This finding is compatible with those of previous cross-sectional and longitudinal studies [67,68,69,70], which found that self-reported pain intensity contributed minimally to opioid craving. This variable is associated with prescription opioid misuse in chronic pain patients receiving long-term opioid therapy [67,71]. A recent longitudinal study found that the association between pain intensity and opioid misuse disappeared when controlling for negative affect and pain catastrophizing [72]. Instead, and in line with our results, a significant association has been found between the severity of prescription opioid misuse and self-reported anxiety and depression [67]. These results challenge the intuitive assumption that patients crave opioid medication due to pain and the relief that they expect to obtain, and instead suggest that opioid misuse is aimed at mitigating unpleasant emotional states. Several studies have found an association between general measures of prescription opioid misuse and pain catastrophizing, defined as ruminating thoughts about the serious threat that pain represents and the lack of personal resources for coping with it [73,74,75,76,77]. Furthermore, an association has been found between increased pain catastrophizing and an increased likelihood of running out of opioid medication early, even after controlling for the patients’ levels of pain intensity and negative affect [72]. Pain catastrophizing has also been associated with increased cravings for prescription opioids [78]. This study found no evidence of an association between pain catastrophizing and opioid misuse. This finding is similar to that of a previous study [79]. The authors explained the discrepancy between the results and those of previous research in terms of the composition of their sample, which they judged to be more heterogeneous and representative of the population of patients treated at a tertiary pain clinic than samples investigated in previous studies. The discrepancy between our results and those reported in previous studies could be due to the assessment tool we used to measure pain catastrophizing. Previous studies have used the Pain Catastrophizing Scale [80], whereas we used the 2-item CSQ [50]. Although these items proved to be valid and reliable, as their authors recognize, they do not completely capture the entire content domain of the catastrophizing construct, which comprises the aforementioned dimensions of rumination, magnification, and helplessness [80]. The results of the present study suggest that anxiety and depression are associated with the misuse of prescription opioids in patients receiving opioid therapy. The relationship between anxiety and depression and substance abuse in general [81] and opioid misuse in particular is a well-documented finding [82,83]; there is also considerable evidence on the comorbidity of chronic pain and mood disorders [84]. Previous studies have consistently found that patients with high levels of anxiety and depression receiving opioid treatment for chronic pain are at increased risk of developing opioid misuse [80,81,82,83,84,85,86,87,88,89,90]. In fact, theories of addiction propose that escape from and avoidance of negative affect is the predominant motive for addictive drug use [91,92]. This perspective suggests that the mechanism sustaining opioid addiction could be a learned association between opioids and relief from an existing dysphoric state, which is formed and maintained by negative reinforcement [93,94]. In order to understand the mechanisms underlying the association between opioid-related and anxiety-related disorders, recent research has addressed transdiagnostic vulnerability factors [95], and specifically, anxiety sensitivity [96], emotion dysregulation [97], pain-anxiety [89], distress intolerance [98], and acceptance [39,40,41] as in the present study. All these factors refer to maladaptive responses to emotional states that are mainly characterized by avoidance, although there is some degree of overlap between them. Thus, there is a need for these results to be integrated into an overarching theoretical model. In this regard, the Psychological Flexibility Model [14] is promising. Until now, most related studies have focused on acceptance and experiential avoidance. Future research could address the role of all the elements of the model in relation to co-morbid anxiety and depression and opioid misuse in chronic pain patients. A research study [99] found that some of the factors associated with opioid misuse are similar to those associated with opioid prescription. In a sample of patients with noncancer chronic pain, the participants who were prescribed opioids were older, reported higher levels of pain intensity and depressive symptoms and reported lower levels of pain-acceptance than those who had not been prescribed opioids. It could be the case that physicians prescribe opioids more frequently to those patients who are at greater risk of opioid misuse. A future line of research would be to simultaneously study the factors involved in the prescription of opioids and the factors involved in their misuse in the same group of participants. · plain
“a significant association was found between higher pain acceptance and lower pain intensity, lower pain catastrophizing, and lower levels of anxiety and depression.”
§ Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain > Abstract
plainstates an associationn = 140- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.3. Structural Equation Modeling · plain
14 more claims
Create a free account to see all 40 claims and every source verdict.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 6
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788 · cited 1×
“The CFI and the NNFI range between 0 and 1: The closer to 1, the better the fit [61].”
BackgroundThe Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Comparative fit indexes in structural models.
Bentler, P. M. (1990) · Psychological Bulletin · doi:10.1037/0033-2909.107.2.238 · Cited by 25,266 · cited 1×
“To reduce the sensitivity of chi-square to sample size, the index is divided by the degrees of freedom [58].”
BackgroundHu, L.-T., & Bentler, P. M. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.424 · Cited by 12,298
The Pain Catastrophizing Scale: Development and validation.
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.4.524 · Cited by 8,227 · cited 2×
“Although these items proved to be valid and reliable, as their authors recognize, they do not completely capture the entire content domain of the catastrophizing construct, which comprises the aforementioned dimensions of rumination, magnification, and helplessness [80].”
BackgroundMethodAcceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 3×
“In this regard, the Psychological Flexibility Model [14] is promising.”
BackgroundCDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Hayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., & Strosahl, K. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.6.1152 · Cited by 3,595
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001384 · Cited by 3,478 · cited 1×
“The International Association for the Study of Pain classification was applied to determine the type of chronic pain [62]: chronic primary pain (56.”
MethodThe Economic Costs of Pain in the United States
Gaskin, D. J., & Richard, P. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.03.009 · Cited by 2,359 · cited 1×
“It has a strong negative impact; is one of the main causes of disability; and entails economic costs higher than those of heart disease, diabetes, and cancer together [2].”
Background
Research works printed but not linked: 5
- Turk, D., and Gatchel, R.J. (2002). Biopsychosocial perspective on chronic pain. Psychological Approaches to Pain Management: A Practitioner’s Handbook, Guilford Press.
- Hayes, S.C., Follette, V.M., and Linehan, M.M. (2004). Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition, Guilford Press. [1st ed.].
- Bissett, 2002, Processes of change: Acceptance versus 12-step in polysubstance-abusing methadone clients, ProQuest Inf. Learn., 63, 10146
- 2015, Hospital Anxiety and Depression Scale (HADS) review in Spanish Samples, Anales Psicología, 31, 494
- Kline, R. (2005). Principles and Practice of Structural Equation Modelling, Guilford Press. [3rd ed.].
Cited by
Fang, S., & Ding, D. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1069748 · Cited by 34
“Chronic pain entails economic costs higher than other diseases, such as heart disease, diabetes, and cancer (Esteve et al., 2021).”
BackgroundDing, D., & Zheng, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.893150 · Cited by 22
Smit, T., Mayorga, N. A., Rogers, A. H., Nizio, P., & Zvolensky, M. J. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107495 · Cited by 15
Filipczyk, P., Filipczyk, K., & Saulicz, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126393 · Cited by 10
“It has been proven that people suffering from chronic lower back pain avoid risky situations, and if they decide to engage in any activity, it is performed with a very high level of caution, which directly affects the quality of a given motor task [14].”
BackgroundIs one-minute difference in operation time meaningful?
Chang, W.-H., Lee, W.-L., & Wang, P. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000539 · Cited by 7
Metadata
- Authors
- Esteve, R., Marcos, E., Reyes-Pérez, Á., López-Martínez, A. E., & Ramírez-Maestre, C.
- Affiliations
- Instituto de Investigación Biomédica de Málaga (ES)
- Facultad de Psicología y Logopedia, Andalucía Tech, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, 29071 Málaga, Spain
- ORCID
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2021-03-16
- Volume
- 18
- Issue
- 6
- Pages
- 3054
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC8002364
- OpenAlex
- W3138730327
- Semantic Scholar
- d5abaedca67b87167dc07bbe52c0a84a0118aaf0
- Cited by
- 17
- References
- 103
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 3
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by)
- Funders
- Ministerio de Ciencia e Innovación (PID2019-106086RB-I00)
- Junta de Andalucía (HUM-566)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- pain acceptance, opioid misuse, chronic non-cancer pain, psychological flexibility, pain catastrophizing, anxiety, depression, pain intensity, acceptance and commitment therapy, opioid prescribing
- MeSH terms
- Analgesics, Opioid, Depression, Emotions, Humans, Prescriptions, Chronic Pain, Prescription Drug Misuse, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain. https://app.cochat.ai/papers/10.3390/ijerph18063054
- The paper
- Esteve, R., Marcos, E., Reyes-Pérez, Á., López-Martínez, A. E., & Ramírez-Maestre, C. (2021). Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph18063054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
